The first pharmacoepidemiology investigations: Notional drug safety policy in the United States, 1901-1902

Perspectives in Biology and Medicine

Volumn 51, Issue 2, 2008, Pages 188-198

  Lilienfeld, David E ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BELLADONNA ALKALOID; DIPHTHERIA ANTIBODY; SMALLPOX VACCINE; VACCINE;

ACT; ADVERTIZING; COMMERCIAL PHENOMENA; DRUG CONTAMINATION; DRUG INDUSTRY; DRUG MANUFACTURE; DRUG MARKETING; DRUG SAFETY; FOOD AND DRUG ADMINISTRATION; HEALTH CARE POLICY; HUMAN; PHARMACOEPIDEMIOLOGY; PRIORITY JOURNAL; REVIEW; TETANUS; UNITED STATES; ARTICLE; DRUG TOXICITY; ECONOMICS; FINANCIAL MANAGEMENT; GOVERNMENT; GOVERNMENT REGULATION; HISTORY; LEGAL ASPECT; POLICY; SMALLPOX;

VARIOLA VIRUS;

DIPHTHERIA ANTITOXIN; DRUG CONTAMINATION; DRUG INDUSTRY; DRUG TOXICITY; FEDERAL GOVERNMENT; GOVERNMENT REGULATION; HISTORY, 20TH CENTURY; HUMANS; MARKETING OF HEALTH SERVICES; PHARMACOEPIDEMIOLOGY; PUBLIC POLICY; SMALLPOX; UNITED STATES; VACCINES;

EID: 43449110446     PISSN: 00315982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (23)

1. Alexander, H. M. 1902a. Letter to Dr. Joseph McFarland, Jan. 20. In the McFarland Paper College of Physicians of Philadelphia (hereafter "McFarland Papers").
2. Alexander, H. M. 1902b. Letter to Dr. Joseph McFarland, Jan. 27. McFarland Papers. College of Physicians of Philadelphia. 1939. Brief outline of the professional career of Joseph McFarland, M.D. McFarland Papers.
3. Davis, H. H., J. W. Fithian, and S. G. Bushey. 1901. Official report of the Camden Board of Health. McFarland Papers.
4. Eyler, J. M. 1986. The epidemiology of milk-borne scarlet fever: The case of Edwardian Britain. Am J Public Health 76:573-84.
5. Galambos, L., and J. E. Sewell. 1995. Networks of innovation. Cambridge: Cambridge Univ. Press.
6. Geiling, E. M. K., and P. R. Cannon. 1938. Pathogenic effects of elixir of sulfanilimide (diethylene glycol) poisoning. JAMA 111:919-26.
7. Hardy, A. 2001. Methods of outbreak investigation in the "era of bacteriology" 1880-1920. Soz Praeventivmed 46:355-60.
8. H. K. Mulford Company. 1901. Letter to Dr. Joseph McFarland, Dec. 3,. McFarland Papers.
9. H. K. Mulford Company. 1902. The exposure of a disreputable proceeding. McFarland Papers.
10. H. K. Mulford Company, n.d. Diphtheria antitoxic serum, 3rd ed. Philadelphia: H. K. Mulford Company. McFarland Papers.
11. Kondratas, R. A. 1982. Biologics Control Act of 1902. In The early years of federal food and drug control, ed. J. H. Young, 8-27. Madison, WI: American Institute of the History of Pharmacy.
12. Kramer, V. H. 1937. The National Institute of Health: A study in public administration. New Haven: Quinnipiack Press.
13. Liebenau, J. 1987. Medical science and medical industry. Baltimore: Johns Hopkins Univ. Press.
14. Lilienfeld, D. E. 1978. The greening of epidemiology: Sanitary physicians and the London Epidemiological Society. Bull Hist Med 52:503-28.
15. Maeder, T. 1994. Adverse reactions. New York: William Morrow.
16. McFarland, J. 1902. Tetanus and vaccination: An analytic study of ninety-five cases of this rare complication. Lancet 2:730-35.
17. McFarland, J. n.d. Details of ninety-five cases of tetanus following vaccination. McFarland Papers.
18. Mulford, H. K. 1901. Letter to Dr. Joseph McFarland, Dec. 6. McFarland Papers.
19. Strom, B. L. 2001. What is pharmacoepidemiology? In Pharmacoepidemiology, 3rd ed., ed. B. L. Strom, 3-15. New York: John Wiley.
20. Toms, S. W. S. 1894. Tetanus complicating vaccinia. Med News 64:209-12.
21. Walsh, R. 1901. Letter to Dr. Joseph McFarland, Dec. 4. McFarland Papers.
22. Willson, R. N. 1902. An analysis of fifty-two cases of tetanus following vaccinia. JAMA 38:1147-52, 1222-31.
23. Wohl, A. S. 1983. Endangered lives: Public health in Victorian Britain. Cambridge: Harvard Univ. Press.